verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: cadila pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler cadila pharmaceuticals limited
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 180 mg/1

Manufacturer
Cadila Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 71209-047
Product ID 71209-047_6c16c48d-a47f-467e-9717-31a7de738b1e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206173
Listing Expiration 2026-12-31
Marketing Start 2017-05-27

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71209047
Hyphenated Format 71209-047

Supplemental Identifiers

RxCUI
897640 897649 897659
UPC
0371209047050
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA206173 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-05)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-10)
source: ndc

Packages (2)

71209-047-05 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-05) 71209-047-10 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-10)

Ingredients (1)

verapamil hydrochloride (180 mg/1)

Linked Drug Pages (1)

VERAPAMIL HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6c16c48d-a47f-467e-9717-31a7de738b1e", "openfda": {"upc": ["0371209047050"], "unii": ["V3888OEY5R"], "rxcui": ["897640", "897649", "897659"], "spl_set_id": ["5501208c-aa2b-47aa-89f7-87f4d4a73fd0"], "manufacturer_name": ["Cadila Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-05)", "package_ndc": "71209-047-05", "marketing_start_date": "20170527"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-10)", "package_ndc": "71209-047-10", "marketing_start_date": "20200214"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "71209-047_6c16c48d-a47f-467e-9717-31a7de738b1e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71209-047", "generic_name": "verapamil hydrochloride", "labeler_name": "Cadila Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "180 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20170527", "listing_expiration_date": "20261231"}